vaccine, claim the jab has been proven to work in tests done on mice and rabbits. A Drug Target Review said the new Ebola virus vaccine design has a lot of advantages compared to standard vaccine approaches for the said virus.In the new jab, the Ebola virus outer Spike or S protein, also identified as glycoprotein, are fastened to the spherical carrier particle's surface, according to The Science Times.The publication explains that the structure of the jab is similar to a typical RNA injection - which is used to treat other viruses such as Covid-19.However, its nanoparticle structure the genetic codes of the optimized glycoprotein, the locking sphere, and the T-cell epitope are all controlled in one piece of DNA.According to the.
Read more on dailystar.co.uk